TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27792869

Group type: EXPERIMENTAL
Intervention: 5 g transdermal testosterone gel (TT) daily for 12 months
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1 mg anastrozole (AI) daily for 12 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo daily for 12 months
Number of subjects: 29
Study: 22457097

Group type: EXPERIMENTAL
Intervention: Extracorporeal cardiac shock wave therapy (CSWT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 25
Study: 20677024

Group type: EXPERIMENTAL
Intervention: Cervical dilatation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-dilated group
Number of subjects: 150
Study: 19583713

Group type: EXPERIMENTAL
Intervention: Itraconazole with lactobacilli (200 mg bid for acute infection followed by monthly single-day treatment)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Itraconazole without lactobacilli (200 mg bid for acute infection followed by monthly single-day treatment)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Classic homeopathy (CH) treatment for 12 months
Number of subjects: 150
Study: 16500299

Group type: EXPERIMENTAL
Intervention: ICD placement
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control (no ICD placement)
Number of subjects: 274
Study: 15014414

Group type: EXPERIMENTAL
Intervention: Fluoride varnish, conventional adhesive
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fluoride varnish, self-etching primer system
Number of subjects: 48

Group type: COMPARATOR
Intervention: No fluoride varnish, conventional adhesive
Number of subjects: 48

Group type: COMPARATOR
Intervention: No fluoride varnish, self-etching primer system
Number of subjects: 48
Study: 11223044

Group type: EXPERIMENTAL
Intervention: Metal wire (stainless steel)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-absorbable polyester (5 Ethibond)
Number of subjects: 37
Study: 9779696

Group type: EXPERIMENTAL
Intervention: CR oxycodone every 12 hours
Number of subjects: 164

Group type: COMPARATOR
Intervention: IR oxycodone four times daily
Number of subjects: 164
Study: 8162750

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation with pressure support ventilation (PSV)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV) alone
Number of subjects: 19
Study: 2735329

Group type: COMPARATOR
Intervention: Cimetidine 200 mg three times daily and 400 mg at night
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g four times daily followed by 1 g twice daily after healing
Number of subjects: 46
Study: 31810793

Group type: EXPERIMENTAL
Intervention: ImmunoCard STAT! HpSA HD (rapid test)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Premier Platinum HpSA PLUS (EIA test)
Number of subjects: 264
Study: 31091579

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 28658082

Group type: EXPERIMENTAL
Intervention: 7-Minute Workout (7Min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: HIIE
Number of subjects: 14
Study: 25528496

Group type: EXPERIMENTAL
Intervention: Pilaralisib 600mg capsules or 400mg tablets once daily
Number of subjects: 67
Study: 23202438

Group type: EXPERIMENTAL
Intervention: Specialized, standardized motor training (3 months)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Low-intensity motor placebo activity (control)
Number of subjects: 91
Study: 22099130

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 60
Study: 19751081

Group type: EXPERIMENTAL
Intervention: Self-affirmation condition (writing two essays on important values over a 2-week period prior to exam)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 15679791

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trospium chloride
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12677739

Group type: EXPERIMENTAL
Intervention: Sinus ultrasound
Number of subjects: 150

Group type: COMPARATOR
Intervention: Clinical examination and symptoms
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sinus ultrasound as a diagnostic criterion
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sinus radiography
Number of subjects: 150
Study: 10574355

Group type: EXPERIMENTAL
Intervention: Shifts of a textured background in the same direction as the target during smooth pursuit initiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shifts of a textured background opposite to the target direction
Number of subjects: 0
Study: 8576779

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk factor modification (cholesterol reduction therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium antagonists and diuretics
Number of subjects: 0
Study: 2614768

Group type: EXPERIMENTAL
Intervention: Restore
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Comfeel Ulcus
Number of subjects: 4

Group type: COMPARATOR
Intervention: DuoDERM
Number of subjects: 4
Study: 884003

Group type: EXPERIMENTAL
Intervention: Clofibate
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Clofibate plus beta-pyridylcarbinol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31174224

Group type: EXPERIMENTAL
Intervention: Endocuff-assisted colonoscopy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 122
Study: 28806348

Group type: EXPERIMENTAL
Intervention: Vitamin E 100 mg/day
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Vitamin E 200 mg/day
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Vitamin E 300 mg/day
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no vitamin E)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Comparison among groups
Number of subjects: 82
Study: 25698164

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) for PTSD
Number of subjects: 50
Study: 23228158

Group type: EXPERIMENTAL
Intervention: BPDSI-IV interview
Number of subjects: 71
Study: 21521539

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate (LC) diet (4 % carbohydrate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Moderate Carbohydrate (MC) diet (35 % carbohydrate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate (LC) diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low Carbohydrate (LC) diet and Moderate Carbohydrate (MC) diet
Number of subjects: 16
Study: 19080128

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with cisplatin and fluorouracil (PF) regimen
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (locoregional treatment alone)
Number of subjects: 8
Study: 16966497

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 5 mg zolmitriptan nasal spray (ZNS5)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 10 mg zolmitriptan nasal spray (ZNS10)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (episodic cluster headache)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 5 mg zolmitriptan nasal spray (ZNS5) (episodic cluster headache)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 10 mg zolmitriptan nasal spray (ZNS10) (episodic cluster headache)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (chronic cluster headache)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 5 mg zolmitriptan nasal spray (ZNS5) (chronic cluster headache)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 10 mg zolmitriptan nasal spray (ZNS10) (chronic cluster headache)
Number of subjects: 92
Study: 12772019

Group type: EXPERIMENTAL
Intervention: Structured exercise program (individualized exercise program performed three times a week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual exercise routine (control group)
Number of subjects: 18
Study: 10852272

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5 (Marcaine)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Physiological saline (Control)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 34
Study: 9199607

Group type: EXPERIMENTAL
Intervention: Ventilation tube insertion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pressure equalization
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pressure variation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Routine implantation of tympanic ventilation tubes
Number of subjects: 40
Study: 1287425

Group type: EXPERIMENTAL
Intervention: Tannin albuminate/ethacridine lactate (TA/EL)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Charcoal
Number of subjects: 186
Study: 3159401

Group type: EXPERIMENTAL
Intervention: Neuramide therapy
Number of subjects: 20
Study: 30166322

Group type: EXPERIMENTAL
Intervention: Urban Training
Number of subjects: 407

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 407
Study: 25727486

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 320
Study: 24158874

Group type: EXPERIMENTAL
Intervention: Extraperitoneal colostomy group (EPC, n=17 after one conversion)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Internal peritoneal colostomy group (IPC, n=18)
Number of subjects: 36
Study: 21593041

Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg/week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mipomersen 300 mg/week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mipomersen (dose not specified, up to 400 mg/week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 18325143

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 16945749

Group type: EXPERIMENTAL
Intervention: Aggressive medical therapy
Number of subjects: 2287

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention plus aggressive medical therapy
Number of subjects: 2287

Group type: EXPERIMENTAL
Intervention: Sequential gSPECT monitoring (n = 300)
Number of subjects: 2287
Study: 14514347

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11479481

Group type: EXPERIMENTAL
Intervention: 20 mg pravastatin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg atorvastatin
Number of subjects: 12
Study: 9756286

Group type: EXPERIMENTAL
Intervention: Interventive treatment (surgical ligation or angiographic embolization of the spermatic vein)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Counselling as the sole treatment
Number of subjects: 125
Study: 8165195

Group type: EXPERIMENTAL
Intervention: Superchar (30 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Actidose (30 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Charcoaid (30 g)
Number of subjects: 0
Study: 3349861

Group type: EXPERIMENTAL
Intervention: Cefoperazone (2 g i.v. every 8 h)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Chloramphenicol (500 mg orally every 6 h)
Number of subjects: 56
Study: 31793045

Group type: EXPERIMENTAL
Intervention: Multiple brief training sessions (three 30-min sessions)
Number of subjects: 66
Study: 31178359

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 28110265

Group type: EXPERIMENTAL
Intervention: Universal health insurance coverage (UHC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 25979104

Group type: EXPERIMENTAL
Intervention: CPAP for 6 months
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 238
Study: 24617226

Group type: EXPERIMENTAL
Intervention: Selective-time-acupuncture group (acupuncture at 9:00am to 11:00am)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture group (acupuncture at any time except 9:00am to 11:00am)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 21835486

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 27
Study: 19083550

Group type: EXPERIMENTAL
Intervention: Fat transplantation using Coleman's technique
Number of subjects: 26
Study: 17140297

Group type: EXPERIMENTAL
Intervention: 4D ultrasound observation in IUGR fetuses
Number of subjects: 100

Group type: COMPARATOR
Intervention: 4D ultrasound observation in normal fetuses
Number of subjects: 100
Study: 12531578

Group type: EXPERIMENTAL
Intervention: Combination treatment (losartan 100 mg daily + trandolapril 3 mg daily)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Trandolapril alone (3 mg daily)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Losartan alone (100 mg daily)
Number of subjects: 336
Study: 10233213

Group type: EXPERIMENTAL
Intervention: Ticlopidine (300 mg daily for 6 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (without ticlopidine)
Number of subjects: 6
Study: 8729142

Group type: EXPERIMENTAL
Intervention: n-3 fatty acid capsules (9 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo capsules (9 g/d)
Number of subjects: 0
Study: 1924664

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Buspirone metabolite 1-pyrimidinylpiperazine (1-PP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 6279230

Group type: EXPERIMENTAL
Intervention: Cefotaxime (48-hour prophylaxis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-treated patients (Control)
Number of subjects: 0
Study: 30902044

Group type: EXPERIMENTAL
Intervention: Musculoskeletal composite score (mean Z-score of five measured traits)
Number of subjects: 3014

Group type: EXPERIMENTAL
Intervention: Physical Activity Scale for the Elderly (PASE) score
Number of subjects: 3014
Study: 28212067

Group type: EXPERIMENTAL
Intervention: PT+stimulant+risperidone (Augmented)
Number of subjects: 103

Group type: COMPARATOR
Intervention: PT+stimulant+placebo (Basic)
Number of subjects: 103
Study: 26713505

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 22798186

Group type: EXPERIMENTAL
Intervention: Stapled or sutured closure plus falciform ligament patch and fibrin glue (FF)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Stapled or sutured closure (SS)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: FF group
Number of subjects: 101

Group type: COMPARATOR
Intervention: SS group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study: 21999297

Group type: EXPERIMENTAL
Intervention: 4.8% CHO plus 2.1% protein (CHO-P)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 6.9% CHO
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 6
Study: 17622258

Group type: EXPERIMENTAL
Intervention: 343 microg [6S]‐5‐CH(3)H(4)PteGlu with 289.4 mg L‐AA
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 343 microg [6S]‐5‐CH(3)H(4)PteGlu with 973.8 mg L‐AA
Number of subjects: 9

Group type: COMPARATOR
Intervention: 343 microg [6S]‐5‐CH(3)H(4)PteGlu
Number of subjects: 9
Study: 16929983

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cells transplanted by intracoronary infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional therapy alone (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cell therapy
Number of subjects: 0
Study: 14525877

Group type: EXPERIMENTAL
Intervention: Secure randomisation of clusters
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Stratified allocation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Imbalance at the cluster level
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Risk of bias at the individual level
Number of subjects: 36
Study: 10780771

Group type: EXPERIMENTAL
Intervention: HFA-BDP (hydrofluoroalkane 134a beclomethasone dipropionate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CFC-BDP (CFC-containing beclomethasone dipropionate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HFA-placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: LPS (lipopolysaccharide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AraLAM (arabinofuranasyl lipoarabinomannan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ManLAM (mannase lipoarabinomannan)
Number of subjects: 0
Study: 8624316

Group type: EXPERIMENTAL
Intervention: Ambulatory monitoring
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional cystometry
Number of subjects: 22
Study: 1653662

Group type: EXPERIMENTAL
Intervention: Beta-hydroxybutyrate (3 mg min-1 kg-1 body weight)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 6837082

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cold Air Inhalation Test (CAIT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cold-stimuli (CPT and CAIT combined)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no cold-stimuli)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cold-stimuli (CPT and CAIT)
Number of subjects: 32
Study: 3768639

Group type: EXPERIMENTAL
Intervention: Domperidone 8 mg intravenously with standard barium sulphate preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg intravenously with standard barium sulphate preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rapid-transit barium (E-Z-Paque, E-Z-Em)
Number of subjects: 0
Study: 29420050

Group type: EXPERIMENTAL
Intervention: Mobile mindfulness meditation using the Headspace application for 30 days (10-20 minutes daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 88
Study: 27455399

Group type: EXPERIMENTAL
Intervention: Use of SMI checklists during simulated obstetric emergencies (eclampsia and PPH)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Use of SMI checklists during simulated obstetric emergencies
Number of subjects: 30
Study: 24966007

Group type: EXPERIMENTAL
Intervention: Integrated care provided by a multidisciplinary team in conjunction with community CKD care network (subdistrict health care officers and VHVs) including group counseling and quarterly home visits.
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Integrated care provided by a multidisciplinary team in conjunction with community CKD care network (subdistrict health care officers and VHVs).
Number of subjects: 500
Study: 22689092

Group type: EXPERIMENTAL
Intervention: A + T (adjuvant anthracycline and taxane chemotherapy)
Number of subjects: 27039
Study: 20130149

Group type: EXPERIMENTAL
Intervention: Abstinence preference
Number of subjects: 742

Group type: COMPARATOR
Intervention: Non-abstinence preference
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 742
Study: 18482157

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 102

Group type: COMPARATOR
Intervention: Naltrexone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Topiramate and Naltrexone
Number of subjects: 102
Study: 16398375

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided brachial plexus anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional landmark-based plexus anaesthesia
Number of subjects: 40
Study: 14611735

Group type: EXPERIMENTAL
Intervention: Image-guided insertion of a Hickman line
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blind insertion of a Hickman line
Number of subjects: 0
Study: 10584626

Group type: EXPERIMENTAL
Intervention: Variant hysterectomy technique
Number of subjects: 262

Group type: COMPARATOR
Intervention: Richardson technique
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 262
Study: 8942555

Group type: EXPERIMENTAL
Intervention: Blunt needle (BN)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sharp needle (SN)
Number of subjects: 200
Study: 1867428

Group type: EXPERIMENTAL
Intervention: Nicardipine (1‐3 micrograms.kg‐1.min‐1, after a titration dose of 4.7 +/‐ 1.5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nitroprusside
Number of subjects: 24
Study: 6297380

Group type: EXPERIMENTAL
Intervention: Topical enviroxime nasal spray
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 31068119

Group type: EXPERIMENTAL
Intervention: Structured early palliative care intervention (Symptoms, End‐of‐life decisions, Network, Support)
Number of subjects: 20
Study: 30358417

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily for 1 month)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Blank control (no intervention)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vitamin E (75 IU daily for 1 month)
Number of subjects: 66
Study: 26403716

Group type: EXPERIMENTAL
Intervention: CS duodenojejunostomy
Number of subjects: 101

Group type: COMPARATOR
Intervention: HS duodenojejunostomy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall incidence of DGE
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Passage of contrast medium through the anastomosis
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Hospital stays
Number of subjects: 101
Study: 25346896

Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg bolus and 0.1 mg/kg/hr, n=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol (20 mg bolus and 0.1 mg/kg/hr, n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (saline, n=30)
Number of subjects: 90